Cambridge Investment Research Advisors
RNXT icon

Cambridge Investment Research Advisors’s RenovoRx RNXT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,900
Closed -$52K – 3271
2023
Q1 		$52K Buy
14,900
+500
+3% +$1.76K ﹤0.01% 3033
2022
Q4 		$34K Hold
14,400
– – ﹤0.01% 3017
2022
Q3 		$29K Hold
14,400
– – ﹤0.01% 2983
2022
Q2 		$29K Hold
14,400
– – ﹤0.01% 2977
2022
Q1 		$42K Hold
14,400
– – ﹤0.01% 3089
2021
Q4 		$70K Sell
14,400
-26,450
-65% -$157K ﹤0.01% 3071
2021
Q3 		$247K Buy
+40,850
New +$340K ﹤0.01% 2629

Other funds holding RNXT

LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
ACA
Affinity Capital Advisors Berkeley, California $810M AUM 24.85% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return